Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05811923 · ClinicalTrials.gov registry record · NA
Changes in Metabolic Rate and Perceptual Indicators After Acute Ingestion of Paraxanthine
A NA study, sponsored by Lindenwood University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT05811923 is a NA study that has completed, run by Lindenwood University. The registered enrollment target is 20 participants.
The verdict
NCT05811923, a NA study, has completed, sponsored by Lindenwood University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the acute impact of ingesting individual and combined dosages of caffeine and paraxanthine in comparison to placebo on changes in resting metabolic rate, perceived levels of affect, and markers of lipolysis.
Interventions
- OTHER Venous Blood Collection
- OTHER Resting Metabolic Rate Determination
- OTHER Mood State
- OTHER Visual Analog Scales
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-12-12 |
| Est. Completion | 2022-10-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05811923
The ClinicalTrials.gov registry entry for NCT05811923 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lindenwood University, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Venous Blood Collection is the first listed.
NCT05811923 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05811923 about?
NCT05811923 is a clinical study titled "Changes in Metabolic Rate and Perceptual Indicators After Acute Ingestion of Paraxanthine". The purpose of this study is to evaluate the acute impact of ingesting individual and combined dosages of caffeine and paraxanthine in comparison to placebo on changes in resting metabolic rate, perceived levels of affect, and markers of lipolysis.
What is the current status of trial NCT05811923?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-12-12. Estimated completion is 2022-10-12.
What interventions are being tested in trial NCT05811923?
The interventions under investigation include: Venous Blood Collection (OTHER), Resting Metabolic Rate Determination (OTHER), Mood State (OTHER), Visual Analog Scales (OTHER).
Who is sponsoring clinical trial NCT05811923?
This trial is sponsored by Lindenwood University, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.